Patent - Abbreviated New Drug Application Cases
Cases 11 - 13 of 13
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court: Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re: In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al. v. Hetero USA, Inc. et al.
as 1:2019cv00751
Plaintiff: Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant: Hetero Drugs, Ltd., Hetero USA Inc., Hetero Labs, Ltd. Unit-V and others
Cause Of Action: 35 U.S.C. § 271
OSI Pharmaceuticals, LLC et al v. Hetero USA Inc. et al
as 1:2017cv00665
Plaintiff: OSI Pharmaceuticals, LLC and Genentech, Inc.
Defendant: Hetero USA Inc., Hetero Labs Ltd. and Hetero Labs Ltd. Unit-V
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?